Kevin Steinke
Stock Analyst at Barrington Research
(4.35)
# 420
Out of 4,761 analysts
141
Total ratings
63.97%
Success rate
12.07%
Average return
Main Sectors:
Stocks Rated by Kevin Steinke
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
KELYA Kelly Services | Maintains: Outperform | $25 | $13.87 | +80.25% | 13 | Feb 18, 2025 | |
CMPR Cimpress | Maintains: Outperform | $119 → $95 | $49.76 | +90.92% | 15 | Jan 31, 2025 | |
ICFI ICF International | Maintains: Outperform | $174 | $100.11 | +73.81% | 10 | Dec 16, 2024 | |
CCRN Cross Country Healthcare | Downgrades: Market Perform | n/a | $18.10 | - | 8 | Dec 10, 2024 | |
HSII Heidrick & Struggles International | Maintains: Outperform | $44 → $50 | $41.41 | +20.74% | 10 | Dec 2, 2024 | |
QUAD Quad/Graphics | Maintains: Outperform | $10 | $5.99 | +66.94% | 6 | Nov 26, 2024 | |
ACCO ACCO Brands | Maintains: Outperform | $7 → $7.5 | $4.56 | +64.47% | 8 | Nov 22, 2024 | |
HQI HireQuest | Maintains: Outperform | $17 → $18 | $14.67 | +22.70% | 10 | Nov 15, 2024 | |
CRD.A Crawford & Company | Maintains: Outperform | $12 → $13 | $11.87 | +9.52% | 9 | Nov 13, 2024 | |
SGC Superior Group of Companies | Maintains: Outperform | $20 → $21 | $14.45 | +45.33% | 11 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $194 → $212 | $200.99 | +5.48% | 9 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $43 → $44 | $28.83 | +52.62% | 10 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $137 → $142 | $123.74 | +14.76% | 16 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $11 | $1.84 | +497.83% | 3 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $0.51 | - | 3 | May 7, 2018 |
Kelly Services
Feb 18, 2025
Maintains: Outperform
Price Target: $25
Current: $13.87
Upside: +80.25%
Cimpress
Jan 31, 2025
Maintains: Outperform
Price Target: $119 → $95
Current: $49.76
Upside: +90.92%
ICF International
Dec 16, 2024
Maintains: Outperform
Price Target: $174
Current: $100.11
Upside: +73.81%
Cross Country Healthcare
Dec 10, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $18.10
Upside: -
Heidrick & Struggles International
Dec 2, 2024
Maintains: Outperform
Price Target: $44 → $50
Current: $41.41
Upside: +20.74%
Quad/Graphics
Nov 26, 2024
Maintains: Outperform
Price Target: $10
Current: $5.99
Upside: +66.94%
ACCO Brands
Nov 22, 2024
Maintains: Outperform
Price Target: $7 → $7.5
Current: $4.56
Upside: +64.47%
HireQuest
Nov 15, 2024
Maintains: Outperform
Price Target: $17 → $18
Current: $14.67
Upside: +22.70%
Crawford & Company
Nov 13, 2024
Maintains: Outperform
Price Target: $12 → $13
Current: $11.87
Upside: +9.52%
Superior Group of Companies
Nov 11, 2024
Maintains: Outperform
Price Target: $20 → $21
Current: $14.45
Upside: +45.33%
Nov 8, 2024
Maintains: Outperform
Price Target: $194 → $212
Current: $200.99
Upside: +5.48%
Nov 6, 2024
Maintains: Outperform
Price Target: $43 → $44
Current: $28.83
Upside: +52.62%
Nov 4, 2024
Maintains: Outperform
Price Target: $137 → $142
Current: $123.74
Upside: +14.76%
Mar 7, 2024
Maintains: Outperform
Price Target: $10 → $11
Current: $1.84
Upside: +497.83%
May 7, 2018
Upgrades: Outperform
Price Target: n/a
Current: $0.51
Upside: -